CN116159006A - 一种富含多种牡丹成分的组合物及其应用 - Google Patents
一种富含多种牡丹成分的组合物及其应用 Download PDFInfo
- Publication number
- CN116159006A CN116159006A CN202310196718.1A CN202310196718A CN116159006A CN 116159006 A CN116159006 A CN 116159006A CN 202310196718 A CN202310196718 A CN 202310196718A CN 116159006 A CN116159006 A CN 116159006A
- Authority
- CN
- China
- Prior art keywords
- peony
- components
- extract
- water
- composition rich
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000736199 Paeonia Species 0.000 title claims abstract description 97
- 235000006484 Paeonia officinalis Nutrition 0.000 title claims abstract description 95
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 239000002537 cosmetic Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000000855 fermentation Methods 0.000 claims description 12
- 230000004151 fermentation Effects 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 230000010355 oscillation Effects 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 241000122904 Mucuna Species 0.000 claims description 2
- 239000010903 husk Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 claims 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 6
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 6
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 6
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 6
- 235000013336 milk Nutrition 0.000 abstract description 6
- 239000008267 milk Substances 0.000 abstract description 6
- 210000004080 milk Anatomy 0.000 abstract description 6
- 239000002023 wood Substances 0.000 abstract description 6
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 abstract description 4
- 229940015975 1,2-hexanediol Drugs 0.000 abstract description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 abstract description 3
- 230000008092 positive effect Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- HFJHNGKIVAKCIW-UHFFFAOYSA-N Stearyl monoglyceridyl citrate Chemical compound OCC(O)CO.OC(=O)CC(O)(CC(O)=O)CC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O HFJHNGKIVAKCIW-UHFFFAOYSA-N 0.000 abstract description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 24
- 239000000523 sample Substances 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 238000011068 loading method Methods 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 240000005001 Paeonia suffruticosa Species 0.000 description 3
- 241001106477 Paeoniaceae Species 0.000 description 3
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- -1 monoterpene glycosides Chemical class 0.000 description 3
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- VQVUBYASAICPFU-UHFFFAOYSA-N (6'-acetyloxy-2',7'-dichloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Cl)=C(OC(C)=O)C=C1OC1=C2C=C(Cl)C(OC(=O)C)=C1 VQVUBYASAICPFU-UHFFFAOYSA-N 0.000 description 2
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 description 2
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 2
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 2
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 2
- 102000015303 Fatty Acid Synthases Human genes 0.000 description 2
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- VFPFQHQNJCMNBZ-UHFFFAOYSA-N ethyl gallate Chemical compound CCOC(=O)C1=CC(O)=C(O)C(O)=C1 VFPFQHQNJCMNBZ-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- FBSFWRHWHYMIOG-UHFFFAOYSA-N methyl 3,4,5-trihydroxybenzoate Chemical compound COC(=O)C1=CC(O)=C(O)C(O)=C1 FBSFWRHWHYMIOG-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- XFZJEEAOWLFHDH-NFJBMHMQSA-N procyanidin B2 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-NFJBMHMQSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000021283 resveratrol Nutrition 0.000 description 2
- 229940016667 resveratrol Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- NTWLPZMPTFQYQI-UHFFFAOYSA-N (3alpha)-olean-12-ene-3,23-diol Natural products C1CC(O)C(C)(CO)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C NTWLPZMPTFQYQI-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PXEZTIWVRVSYOK-UHFFFAOYSA-N 2-(3,6-diacetyloxy-2,7-dichloro-9h-xanthen-9-yl)benzoic acid Chemical compound C1=2C=C(Cl)C(OC(=O)C)=CC=2OC2=CC(OC(C)=O)=C(Cl)C=C2C1C1=CC=CC=C1C(O)=O PXEZTIWVRVSYOK-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- FQWLMRXWKZGLFI-DAFODLJHSA-N 5-[6-hydroxy-2-(4-hydroxyphenyl)-4-[(e)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-DAFODLJHSA-N 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 235000002289 Baccaurea ramiflora Nutrition 0.000 description 1
- 241000891306 Baccaurea ramiflora Species 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 239000004262 Ethyl gallate Substances 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- KLFIUQCKSSAFFU-QHOIGUMUSA-N Galloylpaeoniflorin Natural products O=C(OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@]23[C@]4(COC(=O)c5ccccc5)[C@@H]5O[C@@]2(C)C[C@@](O)(O5)[C@@H]4C3)O1)c1cc(O)c(O)c(O)c1 KLFIUQCKSSAFFU-QHOIGUMUSA-N 0.000 description 1
- GCGBHJLBFAPRDB-UHFFFAOYSA-N Hederagenin Natural products CC1(C)CCC2(CCC3(C)C4CCC5C(C)(CO)C(O)CCC5(C)C4CC=C3C2C1)C(=O)O GCGBHJLBFAPRDB-UHFFFAOYSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 241001007959 Mucuna birdwoodiana Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920002350 Procyanidin B2 Polymers 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- 241001145025 Saussurea involucrata Species 0.000 description 1
- GCGBHJLBFAPRDB-KCVAUKQGSA-N Scutellaric acid Natural products CC1(C)CC[C@@]2(CC[C@@]3(C)[C@@H]4CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2C1)C(=O)O GCGBHJLBFAPRDB-KCVAUKQGSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- ILMMCBFQWHPTHE-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O.CCCC(O)O ILMMCBFQWHPTHE-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000019277 ethyl gallate Nutrition 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- KLFIUQCKSSAFFU-ANNBSXMPSA-N galloylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@@]1(C[C@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=C(O)C(O)=C(O)C=2)O1)O)C)OC(=O)C1=CC=CC=C1 KLFIUQCKSSAFFU-ANNBSXMPSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- PGOYMURMZNDHNS-MYPRUECHSA-N hederagenin Chemical compound C1C[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PGOYMURMZNDHNS-MYPRUECHSA-N 0.000 description 1
- MPGWGYQTRSNGDD-UHFFFAOYSA-N hypericin Chemical compound OC1=CC(O)=C(C2=O)C3=C1C1C(O)=CC(=O)C(C4=O)=C1C1=C3C3=C2C(O)=CC(C)=C3C2=C1C4=C(O)C=C2C MPGWGYQTRSNGDD-UHFFFAOYSA-N 0.000 description 1
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 1
- 229940005608 hypericin Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- IBKQQKPQRYUGBJ-UHFFFAOYSA-N methyl gallate Natural products CC(=O)C1=CC(O)=C(O)C(O)=C1 IBKQQKPQRYUGBJ-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018991 trans-resveratrol Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种富含多种牡丹成分的组合物及其应用,属于梳妆用的配制品领域。包括组分水、丁二醇、1,2‑己二醇、对羟基苯乙酮、牡丹花水、发酵牡丹花水、牡丹枝/花/叶提取物、牡丹根提取物、牡丹籽壳提取物、牡丹籽油、木奶果提取物、雪莲花提取物、甘油硬脂酸酯柠檬酸酯。本发明提供的富含多种牡丹成分的组合物为天然植物来源,满足消费者对于天然的喜好。本发明通过牡丹的各部位综合提取,再复配雪莲花提取物和木奶果,具有明显的协同作用,对皮肤具有多种正面效果,在化妆品应用领域具有很大的应用潜力。
Description
技术领域
本发明属于梳妆用的配制品领域,具体涉及一种富含多种牡丹成分的组合物及其应用。
背景技术
牡丹(PaeoniasuffruticosaAndr.)是芍药科(Paeoniaceae)、芍药属(PaeoniaL.)植物,为多年生落叶灌木。牡丹不仅是中国特有的木本名贵花卉,有数千年的自然生长和2000多年的人工栽培历史,且我国为芍药科植物的野生资源主要分布地,具有明显的先天优势。
在2011年,牡丹籽油被批准为国家新资源食品;而且现在在《已使用化妆品原料目录》中,牡丹根、花、叶、枝、籽的提取物均已有相关的使用记录。但目前针对牡丹的研究为食用方面牡丹籽最多;花、叶较少。对应的,牡丹籽加工产品较多,但产品形式单一(食用牡丹籽油);牡丹花以初级加工产品为主,精深加工较为滞后。
对于牡丹的研究问题主要集中在活性物质不明确、专用加工技术缺乏和产品类型单一的问题。如CN112791126A公开了一种牡丹花蕊提取物及其制备方法与应用,提供了一种具有抑制脂肪酸合酶活性的提取物;但牡丹花蕊的产量稀少,难以实现工业化大规模应用。CN112791127A公开了牡丹花瓣提取物及其制备方法与应用,提供了一种具有抑制脂肪酸合酶活性的提取物;类似的存在花瓣的产量稀少的缺点。
发明内容
本发明提供了一种富含多种牡丹成分的组合物及其应用,对牡丹进行综合利用,并配合其他植物,制备出专门应用于化妆品的原料组合。
为了实现上述目的,本发明采用以下技术方案:
一种富含多种牡丹成分的组合物,以质量份计算包括以下组分:
特别地,所述木奶果提取物的制备方法为:取木奶果的成熟果实,去皮去核,果肉粉碎后浸入乙醇水溶液中加热并电磁振荡提取,提取后取溶液,去除乙醇并浓缩。
进一步的,乙醇水为75vol%,乙醇水与果肉的质量比为8-10:1;
加热的温度为70-76℃,提取时间为2-3h;电磁振荡rpm500-3000,电磁振荡时间为提取时间的≤30%;
浓缩至提取后溶液原体积的≤20%。
特别地,所述发酵牡丹花水的制备方法为:将提取后的牡丹籽壳、牡丹根、牡丹枝/花/叶与牡丹花水、双歧杆菌进行发酵;发酵后灭菌、离心去上清液;
所述提取后的牡丹籽壳、牡丹根、牡丹枝/花/叶的总质量,与牡丹花水,双歧杆菌的质量比为15-25:100:2-4;
发酵初始温度36-37℃,发酵时间36-48h,发酵液初始pH为6-7。
特别地,所述牡丹籽壳提取物的制备方法为:新鲜牡丹籽的脱壳,取籽壳,洗净干燥后粉碎;酶解后灭菌后超临界提取。
进一步的,所述超临界提取中,夹带剂为80-95%vol的乙醇水溶液;CO2的流量为15-28ml/min;萃取温度为40-55℃;压力为35-50Mpa;萃取时间为90-120min;夹带剂的加入量为粉末质量的8-12%。
进一步的,所述酶解中:为纤维素酶,用量为牡丹籽壳的2-5wt%;酶解时间为≥1h,初始温度为55±3℃。
本发明前述的富含多种牡丹成分的组合物在化妆品和/或护肤品中的应用。
甘油硬脂酸酯柠檬酸酯CAS:55840-13-6,是一种植物来源的乳化剂;具有致敏风险低的优点。
丁二醇、1,2-己二醇作为溶剂的同时还具有较强的抑菌功效,无需添加传统防腐剂。
牡丹全株中具有多种不同的活性物质,且在不同部位中各不相同;具体为:
单萜苷类:
芍药苷、氧化芍药苷、苯甲酰芍药苷、没食子酰芍药苷、苯甲酰氧化芍药苷等,主要分布在牡丹籽、根、花、叶中。
低聚茋类:
白藜芦醇、氧化白藜芦醇、反式白藜芦醇醇、葡萄素、葡萄素C等,主要分布在牡丹籽和籽壳中。
酚类:
丹皮酚、没食子酸、没食子酸甲酯、没食子酸乙酯、儿茶素、表儿茶素、原花青素B2、水杨酸等;主要分布在牡丹籽、根、花、叶中。
三萜类:
齐墩果酸、白桦脂酸、羟基白桦脂酸、常春藤皂苷元、角鲨烯等,主要分布在牡丹籽根中。
黄酮类:
芹菜素、槲皮素、木犀草素、芦丁、山奈酚、异鼠李素、金丝桃素、紫云英苷、花旗松素等;主要分布在针丹花、叶、籽中。
另外各部位中还特有:
牡丹花:蓓烯类、醇类、醋类、烷烃类、芳香化合物等挥发性成分。
牡丹籽油:脂肪酸,油酸、亚油酸和亚麻酸等不饱和脂肪酸;棕榈酸、硬脂酸等饱和脂肪酸;甾醇、VE。
牡丹花、叶:单宁类。
雪莲花提取物,为从雪莲花中提取的纯天然产物,能够清除体内自由基,有效延缓肌肤衰老,同时可以帮助肌肤吸收和锁住水分;本发明发现,雪莲花提取物与其他活性物质具有协同作用,对皮肤具有正面影响。
木奶果是原生于我国南方广东、海南等地的较高产量的水果,但是由于不耐运输,故只在原产地附近具有较小的知名度;本发明发现木奶果中具有挥发油、脂肪酸、倍半萜内酯类化合物;与牡丹提取物混用会使得抗氧效果提升。
与现有技术相比,本发明的有益效果为:
(1)本发明提供的富含多种牡丹成分的组合物为天然植物来源,满足消费者对于天然的喜好。
(2)本发明通过牡丹的各部位综合提取,再复配雪莲花提取物和木奶果,具有明显的协同作用,对皮肤具有多种正面效果,在化妆品应用领域具有很大的应用潜力。
具体实施方式
为了更好地理解本发明,下面结合具体实施例对本发明作进一步的描述,其中实施例中使用的术语是为了描述特定的具体实施方案,不构成对本发明保护范围的限制。
本发明中:
牡丹是指PAEONIASUFFRUTICOSA,毛茛科芍药属植物牡丹。
牡丹花水是指PAEONIASUFFRUTICOSAFLOWER WATER;CBNumber:CB79831431。
牡丹枝/花/叶提取物是指PAEONIASUFFRUTICOSAFLOWER/LEAF/ROOT EXTRACT;CBNumber:CB49831430。
牡丹籽油是指PAEONIASUFFRUTICOSASEED OIL(Peony seed oil)CBNumber:CB73373467。
牡丹根提取物是指PAEONIASUFFRUTICOSAROOT EXTRACT,CBNumber:CB5962684。
木奶果是指大戟科、木奶果属Baccaurea ramiflora Lour.。
雪莲花提取物是指SAUSSUREA INVOLUCRATAEXTRACT;CB1964392。
下列实施例中未注明具体条件的实验方法,通常按照常规条件,或按照制造厂商所建议的条件。除非另外说明,否则百分比和份数按重量计算。
木奶果提取物的制备,包括以下步骤:
(1)取木奶果的成熟果实,洗净后去皮去核,取果肉并切碎;
(2)果肉浸泡在75vol%乙醇内,加热提取;并在提取的前段时间内电磁震荡;
(3)提取后分离不溶物取溶液;
(4)溶液分离去除乙醇,浓缩,得木奶果提取物,密封保存备用;具体技术参数如表1所示。
表1
技术参数/序号 | 1 | 2 | 3 |
乙醇水/果肉质量比 | 8 | 9 | 10 |
加热温度,℃ | 76 | 70 | 70 |
提取时间,min | 120 | 180 | 180 |
电磁振荡,rpm | 3000 | 500 | 1500 |
电磁振荡时间,min | 35 | 90 | 60 |
浓缩百分比,v/v% | 20 | 20 | 20 |
牡丹籽壳提取物提取物的制备,包括以下步骤:
(1)取成熟的新鲜牡丹籽的脱壳,取籽壳;洗净干燥后粉碎;
(2)利用纤维素酶酶解,高温灭菌;
(3)CO2超临界提取,夹带剂为乙醇水;得牡丹籽壳提取物,密封保存备用;具体技术参数如表2所示。
表2
发酵牡丹花水的制备,包括以下步骤:
(1)将提取后的牡丹籽壳、牡丹根、牡丹枝/花/叶(残余物)与牡丹花水混合;
(2)利用双歧杆菌进行发酵;
(3)发酵后灭菌、离心去上清液;得发酵牡丹花水,密封保存备用;具体技术参数如表3所示。
表3
技术参数/序号 | 1 | 2 | 3 |
残余物质量份 | 15 | 20 | 25 |
牡丹花水质量份 | 100 | 100 | 100 |
双歧杆菌质量份 | 2 | 3 | 4 |
发酵初始温度,℃ | 36 | 37 | 36 |
发酵时间,h | 36 | 42 | 48 |
发酵液初始,pH | 6.5 | 6 | 7 |
富含多种牡丹成分的组合物的制备,按下表4将各原料混合。
表4
技术参数/实施例编号 | 1 | 2 | 3 | 4 | 5 | 6 |
水 | 14 | 30 | 30 | 48 | 14 | 48 |
丁二醇 | 38 | 11 | 22 | 32 | 38 | 26 |
1,2-己二醇 | 0.128 | 0.039 | 0.220 | 0.160 | 0.130 | 0.240 |
对羟基苯乙酮 | 0.08 | 0.125 | 0.195 | 0.195 | 0.140 | 0.140 |
牡丹花水 | 60 | 42 | 40 | 24.8 | 60 | 28.5 |
发酵牡丹花水 | 12 | 24 | 20 | 12 | 20 | 12 |
发酵牡丹花水序号 | 1 | 1 | 2 | 2 | 3 | 3 |
牡丹枝/花/叶提取物 | 2 | 3 | 2 | 1 | 3 | 2 |
牡丹根提取物 | 1 | 0.5 | 1 | 1.5 | 0.5 | 1 |
牡丹籽壳提取物 | 1.8 | 1.8 | 1.5 | 1.2 | 1.2 | 1.8 |
牡丹籽壳提取物序号 | 1 | 1 | 2 | 2 | 3 | 3 |
牡丹籽油 | 2.5 | 2.5 | 2.5 | 3 | 3 | 3 |
木奶果提取物 | 6 | 7.2 | 8.8 | 6 | 7.2 | 8.8 |
木奶果提取物序号 | 1 | 1 | 2 | 2 | 3 | 3 |
雪莲花提取物 | 0.8 | 0.8 | 1.2 | 0.8 | 0.8 | 1.2 |
甘油硬脂酸酯柠檬酸酯 | 0.4 | 0.4 | 0.2 | 0.4 | 0.4 | 0.2 |
表4中,未注明的技术参数的单位均为质量份。
样品稳定性测试
1、耐热测试:恒温培养箱调节到40℃,将前述制取的六个实施例,每个实施例取三支装于透明玻璃瓶中,装样量为20ml/瓶,封口后置于恒温培养箱内,三个月后取出,恢复至室温,观察外观变化。
2、耐寒测试:恒温培养箱调节到-10℃,将前述制取的六个实施例,每个实施例取三支装于透明玻璃瓶中,装样量为20ml/瓶,封口后置于恒温培养箱内,三个月后取出,恢复至室温,观察外观变化。
3、常温测试:将前述制取的六个实施例,每个实施例取三支装于透明玻璃瓶中,装样量为20ml/瓶,封口后常温下放置6个月后,观察外观变化。
耐热测试、耐寒测试、常温测试均未观察到析出、沉淀等现象,保持原来外观。
人体皮肤斑贴测试
将获得的6组富含多种牡丹成分的组合物参照《2022化妆品安全技术规范》中的人体皮肤斑贴实验。
分别于30min(待压痕消失后)、24h和48h按标准观察皮肤反应,并记录观察结果,见表5。
表5人体安全性测试结果
编号 | 30min | 24h | 48h |
实施例1 | 0级,30人 | 0级,30人 | 0级,30人 |
实施例2 | 0级,30人 | 0级,30人 | 0级,30人 |
实施例3 | 0级,30人 | 0级,30人 | 0级,30人 |
实施例4 | 0级,30人 | 0级,30人 | 0级,30人 |
实施例5 | 0级,30人 | 0级,30人 | 0级,30人 |
实施例6 | 0级,30人 | 0级,30人 | 0级,30人 |
MTT测试
利用MMT测试对样品进行细胞毒性检测。
测试方法:
(1)细胞接种:按2.2*104个/孔的接种密度接种细胞至96孔板,放置培养箱孵育过夜(37℃、5%CO2)。
(2)实验分组:实验设置空白对照组与实验组,另设3个无细胞的孔做调零孔,实验组中样品设置5个浓度梯度,每个梯度浓度下设置3个复孔;
实验组采用实施例1的样品;
(3)配液:按实验设计,用基础培养基配置不同浓度的受试物;如下表6表6 测试浓度设定表
(4)给药:24h后取出96孔板,废除旧培养基,空白对照组每孔加100μL培养液,样品组每孔加入100μL含有相应浓度样品的培养液;调零组无细胞接种,仅加入100μL细胞培养液。给药完成后放回培养箱继续培养。
(5)检测:细胞培养24h后,弃掉上清,加入MTT工作液。37℃避光孵育4h,孵育结束后,弃掉上清,每孔加100μL DMSO,在490nm处读取OD值。
(6)细胞相对活力计算:根据公式计算,结果如表7.
表7积雪草提取物MTT检测结果
ROS(Reactive Oxygen Species)实验测试
以人表皮细胞为研究对象,用一定剂量的UVB照射,建立体外损伤模型。并基于该体外氧化损伤模型,通过样品抑制细胞活性氧的能力来评价待测样品清除自由基功效。
测试方法:
(1)细胞接种:按2.5*105个/孔的接种密度接种至24孔板,培养箱中孵育过夜。
(2)UVB照射:PBS清洗细胞后,根据实验分组,对有UVB照射的组别进行12J/cm2的UVB辐照。
(3)药物诱导:根据表8实验分组,进行分组给药,每孔加样1mL,每组设置3个复孔。给药完成后将24孔板放置在37℃培养箱中避光孵育24h。
(4)ROS探针准备:探针装载前按照1:1000用无血清培养液稀释H2DCFDA,使其终浓度为10μM。
(5)ROS探针装载:吸除处理药物,加入500μL稀释好的H2DCFDA工作液。37℃细胞培养箱内避光孵育30min。
(6)细胞清洗:用PBS清洗细胞3次,以充分去除未进入细胞内的H2DCFDA。
(7)荧光显微镜照相:将清洗好的24孔板置于显微镜下观察。
(8)结果分析:对采集的照片,采用ImageJ软件进行图片荧光强度分析,结果如表9所示。
表8实验分组
表9ROS检测结果
注:与模型进行比较,“*”:P<0.05,表示有显著性差异,“**”:P<0.01、“***”:P<0.001,表示非常显著性差异。
人体测试
受试样品:实施例1-6,不稀释。
受试人群:年龄在25-50岁之间的70位女性;
皮肤状况:过敏测试无过敏,受试部位皮肤无异常、明显疤痕或损伤;
分组:分成7组,每组10人,各组人员均匀分配;
测试方法:受试者在测试前三天及整个测试期间,不涂抹除测试样品外的任何化妆品和外用试剂,测试前,受试者首先用无任何功效的洗面奶清洁脸部,使用皮肤水分测试仪Corneometer CM 825测量受试者皮肤含水量,然后取适量受试品均匀涂于一侧面部,另一侧面部不涂抹任何护肤品作为空白对照区域,在涂抹前(0h)、涂抹后分别于1小时、3小时、6小时使用皮肤水分测试仪Corneometer CM 825测量受试区域和空白对照区域的皮肤含水量,每位受试者面部取3个不同的位置进行测试后记平均值。测定结束后计算水分含量(MMV)均值,结果见下表10:
表10即时保湿性能结果
虽然以上描述了本发明的具体实施方式,但是本领域的技术人员应当理解,这仅是举例说明,本发明的保护范围是由所附权利要求书限定的。本领域的技术人员在不背离本发明的原理和实质的前提下,可以对这些实施方式做出多种变更或修改,但这些变更和修改均落入本发明的保护范围。
Claims (8)
2.根据权利要求1所述的富含多种牡丹成分的组合物,其特征在于,所述木奶果提取物的制备方法为:取木奶果的成熟果实,去皮去核,果肉粉碎后浸入乙醇水溶液中加热并电磁振荡提取,提取后取溶液,去除乙醇并浓缩。
3.根据权利要求2所述的富含多种牡丹成分的组合物,其特征在于,乙醇水为75vol%,乙醇水与果肉的质量比为8-10:1;
加热的温度为70-76℃,提取时间为2-3h;电磁振荡rpm500-3000,电磁振荡时间为提取时间的≤30%;
浓缩至提取后溶液原体积的≤20%。
4.根据权利要求1所述的富含多种牡丹成分的组合物,其特征在于,所述发酵牡丹花水的制备方法为:将提取后的牡丹籽壳、牡丹根、牡丹枝/花/叶与牡丹花水、双歧杆菌进行发酵;发酵后灭菌、离心去上清液;
所述提取后的牡丹籽壳、牡丹根、牡丹枝/花/叶的总质量,与牡丹花水,双歧杆菌的质量比为15-25:100:2-4;
发酵初始温度36-37℃,发酵时间36-48h,发酵液初始pH为6-7。
5.根据权利要求1所述的富含多种牡丹成分的组合物,其特征在于,所述牡丹籽壳提取物的制备方法为:新鲜牡丹籽的脱壳,取籽壳,洗净干燥后粉碎;酶解后灭菌后超临界提取。
6.根据权利要求5所述的富含多种牡丹成分的组合物,其特征在于,
所述超临界提取中,夹带剂为80-95%vol的乙醇水溶液;CO2的流量为15-28ml/min;萃取温度为40-55℃;压力为35-50Mpa;萃取时间为90-120min;夹带剂的加入量为粉末质量的8-12%。
7.根据权利要求5所述的富含多种牡丹成分的组合物,其特征在于,所述酶解中:为纤维素酶,用量为牡丹籽壳的2-5wt%;酶解时间为≥1h,初始温度为55±3℃。
8.权利要求1-7任一所述的富含多种牡丹成分的组合物在化妆品和/或护肤品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310196718.1A CN116159006B (zh) | 2023-03-03 | 2023-03-03 | 一种富含多种牡丹成分的组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310196718.1A CN116159006B (zh) | 2023-03-03 | 2023-03-03 | 一种富含多种牡丹成分的组合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116159006A true CN116159006A (zh) | 2023-05-26 |
CN116159006B CN116159006B (zh) | 2023-12-19 |
Family
ID=86419928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310196718.1A Active CN116159006B (zh) | 2023-03-03 | 2023-03-03 | 一种富含多种牡丹成分的组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116159006B (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751058A (zh) * | 2014-01-10 | 2014-04-30 | 河南科技大学 | 一种牡丹护肤品及其制备方法 |
CN105078875A (zh) * | 2015-09-06 | 2015-11-25 | 菏泽瑞璞牡丹产业科技发展有限公司 | 一种含牡丹提取物的化妆品及其制备方法 |
CN106422403A (zh) * | 2016-09-27 | 2017-02-22 | 桂林茗兴生物科技有限公司 | 一种木奶果提取物的制备方法 |
WO2017053569A1 (en) * | 2015-09-23 | 2017-03-30 | Amyris, Inc. | Compositions and methods for extraction of botanical compounds from plants |
KR20190013121A (ko) * | 2017-07-31 | 2019-02-11 | 주식회사 솔레온 | 모란 혼합 추출물을 함유한 피부개선용 화장료 조성물의 제조방법 및 이를 포함하는 화장료 조성물 |
CN114392219A (zh) * | 2022-01-29 | 2022-04-26 | 清远市望莎生物科技有限公司 | 具有舒缓功效的牡丹提取物组合物及其制备方法与应用 |
CN115252500A (zh) * | 2022-08-25 | 2022-11-01 | 山东贝世康生物科技有限公司 | 含有牡丹提取物的护肤组合物及其应用 |
CN115414293A (zh) * | 2022-08-26 | 2022-12-02 | 广州环亚化妆品科技股份有限公司 | 一种抗衰老组合物及其应用 |
-
2023
- 2023-03-03 CN CN202310196718.1A patent/CN116159006B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751058A (zh) * | 2014-01-10 | 2014-04-30 | 河南科技大学 | 一种牡丹护肤品及其制备方法 |
CN105078875A (zh) * | 2015-09-06 | 2015-11-25 | 菏泽瑞璞牡丹产业科技发展有限公司 | 一种含牡丹提取物的化妆品及其制备方法 |
WO2017053569A1 (en) * | 2015-09-23 | 2017-03-30 | Amyris, Inc. | Compositions and methods for extraction of botanical compounds from plants |
CN106422403A (zh) * | 2016-09-27 | 2017-02-22 | 桂林茗兴生物科技有限公司 | 一种木奶果提取物的制备方法 |
KR20190013121A (ko) * | 2017-07-31 | 2019-02-11 | 주식회사 솔레온 | 모란 혼합 추출물을 함유한 피부개선용 화장료 조성물의 제조방법 및 이를 포함하는 화장료 조성물 |
CN114392219A (zh) * | 2022-01-29 | 2022-04-26 | 清远市望莎生物科技有限公司 | 具有舒缓功效的牡丹提取物组合物及其制备方法与应用 |
CN115252500A (zh) * | 2022-08-25 | 2022-11-01 | 山东贝世康生物科技有限公司 | 含有牡丹提取物的护肤组合物及其应用 |
CN115414293A (zh) * | 2022-08-26 | 2022-12-02 | 广州环亚化妆品科技股份有限公司 | 一种抗衰老组合物及其应用 |
Non-Patent Citations (1)
Title |
---|
邓浩: "《木奶果花色苷提取纯化及其抗氧化活性研究》", 《食品研究与开发》, vol. 37, no. 21, pages 32 - 36 * |
Also Published As
Publication number | Publication date |
---|---|
CN116159006B (zh) | 2023-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101126315B1 (ko) | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화 방지 또는 항산화용 조성물 | |
CN104758198B (zh) | 一种含黑莓提取物的强抗氧化护肤品及其制备方法和用途 | |
KR101723526B1 (ko) | 동백꽃, 벚꽃, 쟈스민꽃, 캐모마일꽃 및 연꽃 혼합추출물을 함유하는 화장료 조성물 | |
KR102104225B1 (ko) | 가수분해효소 및 초고압 유화기를 활용하여 유효성분을 증대시킨 더덕 캘러스 추출물의 제조 방법 | |
KR20110092721A (ko) | 인삼사포닌Rg1과 복령발효산물을 이용한 천연 한방화장품 | |
KR20170141497A (ko) | 황칠나무와 한약재료의 효소 추출물을 이용하는 탈모개선 샴푸의 제조 방법 | |
JP5921056B2 (ja) | 美容用組成物 | |
CN108042436B (zh) | 蓝铜胜肽抗衰保湿精华霜 | |
KR102381564B1 (ko) | 한국산 산삼 캘러스 세포배양에 의하여 얻어진 고수율 진세노사이드 생합성유도 조성물 및 이의 용도 | |
KR101769755B1 (ko) | 엘라스테이즈 저해 효능이 향상된 류코노스톡 메센테로이데스 gfc 160704 균주, 상기 균주 또는 이의 배양액을 포함하는 주름 개선용 화장료 조성물 및 이의 제조 방법 | |
KR101346693B1 (ko) | 뽕나무의 잎, 줄기, 뿌리 껍질, 열매의 추출물을 이용한 피부개선 화장료 조성물 제조방법 및 이로부터 제조된 화장료 조성물 | |
CN116159006B (zh) | 一种富含多种牡丹成分的组合物及其应用 | |
KR101496926B1 (ko) | 황금, 황련, 황백, 작약 및 루이보스의 혼합 추출물을 함유하는 가려움 예방 및 비듬 개선용 화장료 조성물 | |
CN113631227A (zh) | 抗老化剂、抗氧化剂、抗炎剂、及美白剂、以及化妆品 | |
KR102029546B1 (ko) | 무궁화의 꽃, 뿌리, 캘러스 및 씨의 혼합 추출물을 유효성분으로 함유하는 항노화 및 항알러지용 화장료 조성물 및 그 제조방법 | |
CN113143835B (zh) | 一种除螨祛痘植物组合酵素及其制备方法与应用 | |
CN112043650B (zh) | 一种祛痘修复化妆品制剂及其制备方法 | |
CN107823114A (zh) | 一种含有黄精干细胞提取物的祛痘护肤品 | |
CN109276519B (zh) | 一种七叶一枝花发酵原液及其制备方法和应用 | |
KR101567325B1 (ko) | 국화 추출물을 포함하는 식품 조성물 | |
KR102520908B1 (ko) | 영여자 숙성액의 제조 방법 및 이에 의해 제조된 영여자 숙성액 | |
KR20200046203A (ko) | 황칠나무 잎 추출물 및 한라봉 껍질 추출물을 함유하는 발모개선조성물 | |
CN109700716A (zh) | 一种构树花、鲜果活性成分提取方法及提取物的应用 | |
KR102112963B1 (ko) | 산양산삼 식초를 이용한 피부 치료 및 개선용 조성물 | |
KR102710704B1 (ko) | 생물 전환된 때죽나무 캘러스 추출물을 포함하는 화장료 조성물 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |